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Dr Bonded
doi:10.1016/j.jtcvs.2006.07.044bjectives: The reasons for the increasing incidence of esophageal adenocarcinoma
re not clear. A causal relation between gastroesophageal reflux disease and esoph-
geal adenocarcinoma has been suggested. Support for this comes from the devel-
pment of esophageal adenocarcinoma in the rat reflux model. However, to date, no
ystematic characterization of the tumors derived from this model has been reported.
ethods: We induced biliary reflux by creating esophagojejunal anastomoses in 12
prague–Dawley rats. The experiment was terminated at 9 months, and rat esophagi
ere harvested for histopathologic documentation of reflux-associated changes and evi-
ence of tumor formation. Three cell lines were established from 2 of the reflux-associated
umors. We tested the ability of these cells to grow in vitro in tissue culture and in vivo as
enografts in an orthotopic location at the gastroesophageal junction. Furthermore, we
erformed a cytogenetic analysis and determined the array-based gene expression
rofiles of these 3 rodent carcinoma lines compared with normal esophageal mucosa.
esults: At 9 months, 12 of 12 rodents had histologic features of metaplastic columnar
pithelium in the esophagus, with 7 having invasive carcinomas with glandular differ-
ntiation (either adenocarcinomas or adenosquamous carcinomas). The 3 cell lines
stablished from 2 reflux-associated tumors were capable of sustained in vitro propa-
ation and grew successfully as xenografts in both subcutaneous and orthotopic loca-
ions, confirming the tumorigenic nature of these lines. Despite their establishment from
rimary tumors with glandular features, the histology of the xenografts was that of
ell-differentiated squamous carcinomas. Karyotype analyses demonstrated cytogenetic
eterogeneity and aneuploidy; furthermore, translocation (7:11) was present in all 3
ines. Array-based gene expression profiling confirmed upregulation of several cancer-
elated genes important in human esophageal cancer. Quantitative reverse transcription–
olymerase chain reaction was used to confirm the differential expression of selected
ranscripts (vascular endothelial growth factor [VEGF], polo-like kinases [PLK], cyclin
ependent kinase 4 [CDK4], hypoxia-inducible factor 1 [HIF1], and insulin-like growth
actor 1 [IGF-1]) in comparison with nonneoplastic esophageal mucosal scrapings.
onclusions: The rodent reflux model is capable of inducing metaplastic epithelial
hanges simulating Barrett esophagus, as well as subsequent neoplastic transformation, at a
igh frequency. Cell lines have been established from these tumors that are capable of in
itro and in vivo passaging. The rodent reflux model should be a valuable model for studying
herapy and chemoprevention efforts for Barrett esophagus, whereas the established cell
ines provide a useful resource for drug discovery and other high-throughput studies.
 
he increasing incidence of esophageal adenocarcinoma has necessitated a
search for the causes leading to this epidemic.1 Epidemiologic studies have
confirmed that this increase in the incidence of esophageal adenocarcinoma
s strongly related to a similar increase in the incidence of gastroesophageal reflux
isease.2 How gastroesophageal reflux might be responsible for the development of
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G
TSsophageal cancer is still not fully understood. However,
here are ample data from preclinical and clinical studies
emonstrating that gastroesophageal reflux disease is inju-
ious to the esophageal mucosa.3,4
An animal model that is used for studying esophageal
arcinogenesis is based on the rat reflux model originally
roposed by Levrat and colleagues5 to study the effect of
sophagitis induced after gastrectomy. This model has been
xtensively used, with and without carcinogens, to study
arious components of the refluxate.6-8 Others have used
odifications of this original model to study carcinogenesis
nd chemoprevention.9-11 For example, it has been shown
hat the reflux model does not need the carcinogen to induce
sophageal tumors,12 and the pure reflux model has been
sed in chemopreventive studies using inhibitors of cyclo-
xygenase 2.9,10 To date, there have been no attempts to
onfirm the malignant character of these tumors by growing
hem in vitro or in vivo. In addition, the exact genetic
haracteristics of these tumors are unclear and have not
een systematically studied. The aim of the present exper-
ment was to assess the malignant potential of cells from
his model based on the ability of malignant, but not normal,
ells to transform and grow in tissue culture and to examine
hromosomal and genetic alterations in these tumors.
aterials and Methods
ll procedures were prospectively approved by the Animal Care
nd Use Committee of Johns Hopkins University, and the animals
eceived humane care in compliance with the “Guide for the care
nd use of laboratory animals,” published by the National Re-
earch Council (National Academy Press, 1996). Animals were
cclimatized in a central animal facility for 2 weeks before the
xperiment. Rats and mice were anesthetized with an intramuscu-
ar injection of ketamine and xylazine.
urgical Model of Reflux-induced Esophageal Tumors
iliary reflux was induced in 10-week-old male Sprague–Dawley
ats (200-250 g, Harlan). The animals were allowed 2 weeks to
cclimatize and were housed at a temperature of 20°C to 22°C and
humidity of 30% to 50% at 12-hour alternating light-dark cycle.
he rats were fasted overnight but allowed water ad libitum until
he operation. Briefly, the esophagus was mobilized, preserving the
agus nerves, and a loop of jejunum was then identified 4 cm from
Abbreviations and Acronyms
CDK-4  cyclin dependent kinase 4
HIF1  hypoxia-inducible factor 1
IGF-1  insulin-like growth factor
PLK  polo-like kinases
RT-PCR  reverse transcription–polymerase chain
reaction
VEGF  vascular endothelial growth factorhe ligament of Treitz. The gastroesophageal junction was divided s
64 The Journal of Thoracic and Cardiovascular Surgery ● Marcnd ligated, and an end-to-side anastomosis was constructed be-
ween the distal esophagus and jejunum (modified Levrat’s model5).
nce the animals awoke, they were allowed water ad libitum; the
eeds recommenced the following day. Animals received appro-
riate analgesia during the perioperative and postoperative periods.
he experiment concluded 9 months postoperatively.
arvesting of the Tumors
bdominal and thoracic viscera were exposed through a midline
ncision, and the tumors were assessed for size and extent. The
sophagus was mobilized from the neck down to and including
he esophagojejunal anastomosis. The tumors were identified and
arefully dissected away from the liver and adjoining structures.
he esophagus was opened longitudinally to expose the lumen; a
mall representative tissue was then excised from the tumor mass
nd preserved in 10% formalin for histologic examination. The
umors were then harvested and washed immediately with phos-
hate-buffered saline solution to remove any food debris and
ontaminants and then stored in phosphate-buffered saline at 4°C
nd transported to the laboratory for tissue culture.
n Vitro Growth (Establishment of the Cell Lines)
umors were mechanically minced and enzymatically digested
ith collagenase. The disaggregated cells were then plated in
ppropriate growth media as a primary culture. The culture plates
ere checked for the presence of cancer cells everyday. After
dequate growth, single clones were picked by using a cloning ring
nd transferred to 96-well plates. We froze and stored aliquots of
he original lineage.
n Vivo Growth in Athymic Mice
ix- to 10-week-old female CD1 null/null mice (weight, 13-16 g)
ere used (Charles River Company). They were kept in wire cages
n a low-pathogen environment (temperature, 20°-22°C; humidity,
0%-50%; 12-hour/12-hour light-dark cycle). Autoclaved chow
ellets and water were available ad libitum.
Establishment of JA, JB, AMY cell line–derived tumor speci-
ens. Approximately 5 106 cells (with 0.1 mL of Matrigel [BD
iosciences] and cells in 0.1 mL of Hank’s buffered salt solution)
ere injected subcutaneously into a CD1 null/null mouse. Four
eeks after implantation, the resulting tumors were explanted and
ut into pieces of approximately 1 mm3. These cubes were then
mplanted subcutaneously in the CD1 null/null mice to obtain
table tumor growth. Tumors from these animals were examined
y means of routine hematoxylin and eosin staining.
Surgical orthotopic implantation of JA, JB, AMY cell line–
erived tumor specimens. After 1 passage, the tumor was har-
ested and cut into cubes of approximately 10 to 20 mm3. Tumor
ieces were mixed to receive a homogeneous distribution of spec-
men from the center and the margin of the tumor. These pieces
ere subsequently implanted in 3 mice, respectively, by using
icrosurgical techniques. The stomach was exteriorized through a
eft-sided upper abdominal incision, and the serosa of the anterior
all of the forestomach (which has the similar histologic pattern as
he esophagus) was removed with a scalpel. One tumor cube was
ewn on the prepared gastric wall with 8-0 nonabsorbable sutures.
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G
TShe laparotomy was closed in 2 layers with 6-0 non-absorbable
utures. Animals were killed 4 weeks later.
ytogenetics
ells at 75% confluency were arrested in metaphase with 0.05
g/mL Colcemid (Sigma, St Louis, Mo). Ethidium bromide was
dded at a final concentration of 0.05 mg/mL. Approximately 4
ours later, the monolayer was detached with trypsin, incubated at
7°C in 0.075 mol/L KCl for 10 minutes, and fixed in 3:1 meth-
nol/acetic acid. Slides were prepared and G-banded by using
tandard techniques. At least 50 cells from each cell line were
nalyzed. Representative metaphases were photographed and
aryotyped.
icroarray Analysis, Data Normalization, and Gene
ntology Analysis of Differentially Expressed Genes
at 8Kx2 cDNA microarrays were obtained from the Johns Hop-
ins Cancer Center Microarray Core. They contain 8000 genes and
xpressed sequence tags double printed on site from a cDNA set
enerated by the Institute for Genomic Research. The microarray
ene list is available on request. Total cellular RNA was isolated
ith the RNeasy RNA extraction kit (Qiagen), according to the
anufacturer’s protocol. Parallel experiments were performed
ith a common reference design, in which 3 rat cancer cell lines
JA, JB, and AMY) were compared with reference normal rat
sophageal mucosal cells (Normalpooled; ie, a 1:1 mixture of Nor-
al1:Normal). The design included a dye swap for each compar-
son to minimize the effects of dye bias.13 The aims of the
icroarray study were to identify 2-fold or greater differentially
xpressed genes in each cell lines relative to normal values and to
xamine differentially expressed genes common to all 3 dye-swap
airs to identify cancer-related genes. Statistical analysis of the
icroarray data was performed with GeneTraffic software (Iobion
nformatics). Problematic spots were flagged for exclusion from
ggregate statistical calculations and normalization based on
1) raw signal intensity to a background intensity ratio of less than
, (2) raw signal of less than 1 times average background, and (3)
aw intensity of less than 150. Spot signals were normalized by
sing Lowess subgrid normalization. Differentially expressed tran-
cripts were defined as spots with a mean log base 2 ratio absolute
alue of 2 or greater (ie, log base 2 ratio  or  1), and gene lists
ere compiled for spots meeting this criterion for each of the 3
ye-swap pairs. Final gene lists identifying differentially expressed
ranscripts common to all 3 dye swaps were created from the raw
ists by using an intersection set operator. Onto-Express14 analysis
as performed on differentially regulated gene lists to construct
unctional profiles by using Gene Ontology15 terms for the fol-
owing categories: biological process, cellular component, and
olecular function. Onto-Express calculates statistical significance
alues (P values) for functional categories of genes within a profile
y using a hypergeometric distribution in conjunction with a
alse-discovery rate probability correction method to compare the
bserved number of genes in a given category with the entire
omplement of genes within that category on the array. The P
alues distinguish between significantly overrepresented func-
ional classes of genes and those representing random events. We
ocused our attention on functional categories containing at least 2
enes at a P value of less than .05. c
The Journal of Thoracicuantitative Reverse Transcription–Polymerase Chain
eaction for Detection of Genes of Interest
otal cellular RNA was isolated with the RNeasy RNA extraction
it (Qiagen), according to the manufacturer’s protocol, and reverse
ranscription to cDNA was performed by using oligo dT synthesis
Invitrogen). All assays were carried out in 25-L volumes for the
mart Cycler. Rat-specific reverse transcription–polymerase chain
eaction (RT–PCR) primers were obtained from Applied Biosys-
ems by using the Assay-by-Demand platform for prefabricated
aqMan assays and amplified by using ABI’s Universal master
ix. Thermal cycling for the Smart Cycler was performed as
ollows: 1 cycle at 95°C for 15 minutes, followed by 45 cycles of
4°C for 1 second and 56°C for 30 seconds and extension at 76°C
or 30 seconds. Rat phosphoglycerate kinase 1 was used as a
ousekeeping gene for normalization of RT-PCR data, and the
-Ct method was used for calculating relative fold differential
xpression of candidate genes in the 3 cell lines compared with rat
ormal esophageal mucosal scrapings.
esults
istology of Reflux-associated Metaplasia
nd Neoplasia
ll 12 rodents had hyperplastic esophageal epithelium with
everal layers of esophageal epithelial cells (Figure E1, A).
here was also evidence of mucosal ulceration and inflam-
ation in the esophageal mucosa. All animals showed the
resence of islands of columnar epithelium and tubular
ucosal glands, with features both of mucous secretory and
bsorptive cells with interspersed intestinal-type goblet
ells. In animals in which tumors developed, the islands of
arrett mucosa (Figure E1, B) were closely related to the
esions and sometimes formed the margin of the esophageal
denocarcinomas and adenosquamous cancers. The areas of
olumnar metaplasia extended upward from the anastomotic
ite for several millimeters. Some of the hyperplastic epi-
helium showed the presence of goblet cells, particularly in
he basal layers. The morphological features of the jejunal
ucosa were significantly distinct from those of the meta-
lastic epithelium. At 9 months postoperatively, 9 (75%) of
2 rodents had esophageal tumors. Four had esophageal
denocarcinomas (Figure E1, C), 2 had squamous cell car-
inomas, and 3 had adenosquamous carcinomas (Figure E1,
). All of the tumors were located above the esophagoje-
unal anastomosis. Some of the tumors showed invasion of
he submucosa (Figure E1, E). Mucin-secreting cells were
bvious, even on hematoxylin and eosin stains, in the tu-
ors with glandular differentiation (Figure E1, F).
n Vitro Characteristics of Esophageal Cancer
ell Lines
ll 9 tumors were successful as primary cultures; however,
nly 5 could survive subsequent subculture at weekly inter-
al. Two cell lines were found to be contaminated by
andida species and were abandoned. Finally, 3 cell lines
ould be established from 2 cancers, JA and JB from one
ancer and AMY from another. The underlying histology of
and Cardiovascular Surgery ● Volume 133, Number 3 765
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7
G
TShe primary tumor from which JA and JB cell lines were
stablished was adenosquamous, whereas the AMY cell line
as established from an adenocarcinoma. These cell lines
ave replicated continuously for more than 50 population
oublings. We froze aliquots of the original cells at regular
ntervals. There has been no morphological change noticed
n all 3 cell lines over this period. The cytospin histology of
A and JB cell lines demonstrates that they consist of
ell-differentiated squamous cell cancer; cytospin prepara-
ions of the AMY cell line showed some presence of mu-
inous cells (Figure E2).
n Vivo Characteristics of Subcutaneous Implants
hree cell lines, JA, JB, and AMY, grew subcutaneously
n 4 for each cell line) in either flank, and at 4 weeks after
mplantation, they grew to a diameter of 1.7  0.5 cm (JA
ell line), 1.9  0.4 cm (JB cell line), and 1.7  0.7 cm
AMY cell line), respectively. All the cell lines grew dif-
erentiated squamous cell cancers (Figure E3, A).
n Vivo Characteristics of Orthotopic Transplants
ll the orthotopic implants at the gastroesophageal junction
rew successfully (n  3 per cell line) and reached greater
han 1.5 cm in diameter in 4 weeks. The histology of these
rthotopic xenografts also revealed well-differentiated
quamous cell cancers for all 3 cell lines (Figure E3, B).
aryotype Analyses
ll 3 cell lines were very heterogeneous and aneuploid,
ith chromosome numbers in the near-tetraploid range.
hromosome gains and losses appeared to be somewhat
andom, although chromosomes 17 and 18 tended to be
verrepresented, and chromosome 19 tended to be under-
epresented. Occasional nonclonal structural changes in
he chromosomes were also seen. All cell lines had lost
he Y chromosome.
JA cell Line. This line had 2 major clones. The first had
modal chromosome number of 80, with a chromosome 4
hat had a deletion of the long arm at band q22 (Figures E4,
.1, and E5) and a translocation consisting of what appeared
o be an intact chromosome 8 and the whole short arm of
hromosome 17 (Figures E4, A.1, and 5, C). The second
lone had a modal number of 78 and 2 translocations, the
:17 translocation seen in the first clone and a second
ranslocation that appeared to be an intact chromosome 7
nd most of the long arm of chromosome 11 with the
reakpoint in band q11 (Figures E4, A.2, and E5, B). A
epresentative karyotype is depicted in figure E4, A.3.
JB cell line. The JB cell line contained 2 major clones.
he first had the same 8:17 translocation seen in the JA cell
ine (Figures E4, B.1, and E5, C), and the other had both
:11 and 8:17 translocations observed in the JA cell line
Figures E4, B.2; E5, B; and E5, C). The modal chromo-
ome number of both clones was 78 (Figure E4, B.3). c
66 The Journal of Thoracic and Cardiovascular Surgery ● MarcAMY cell line. The AMY cell line had a modal number
f 80 (Figure 4, C.2) and the 7:11 translocation seen in both
he JA and JB cell lines (Figures E4, C.1, and E5, B).
ene Expression Profile by Means of
DNA Microarray
e observed that 1409 transcripts exhibited a 2-fold or
reater differential expression in the JA cell line compared
ith the normal pooled sample (573 upregulated and 836
ownregulated), the JB cell line had 1186 transcripts with
-fold or greater differential expression (474 upregulated
nd 712 downregulated), and the AMY cell line had 1070
ifferentially expressed transcripts (390 upregulated and 680
ownregulated). By using an intersection set operator, the
xpression of 676 transcripts was observed to be 2-fold or
reater differentially expressed in all 3 cancer cell lines relative
o pooled normal squamous mucosa, including 455 downregu-
ated and 219 upregulated transcripts (representative subset in
able E1). Using Ontogene Express, we discovered that the
verexpressed transcripts had a significant overrepresentation
f genes related to regulation of cell cycle, cytoskeleton rear-
angements, cytokine activity, apoptosis-related events, and
rotein serine threonine activity (Table E2). Similarly, we
iscovered that the transcripts with decreased expression in
esponse to the condition under study had a significant over-
epresentation of proteolysis, metalloendopeptidase activity,
lutathione S-transferase activity, extracellular matrix-related
ctivity, and hydrolase- and zinc-binding activity. Several of
hese genes have shown to be of importance in the human
sophageal cancers, both squamous and Barrett-associated
denocarcinomas. In compliance with the recommendations
f the Microarray Gene Expression Data Society (http://
ww.mged.org/), the microarray data for this study were
eposited at the National Center for Biotechnology Infor-
ation’s Gene Expression Omnibus (http://www.ncbi.nlm.
ih.gov/geo/) and are accessible through the Gene Expres-
ion Omnibus series accession number GSE1707.
uantitative RT-PCR of Genes of Interest
e further investigated the relative expression of a subset
f 5 genes of interest by means of RT-PCR in the 3 esoph-
geal cancer cell lines versus rat normal esophageal muco-
al scrapings. These genes were selected based on known
oles in human esophageal cancers. 16-20 The expression of
ascular endothelial growth factor (VEGF), polo-like ki-
ases (PLK), cyclin dependent kinase 4 (CDK4), hypoxia-
nducible factor 1 (HIF1), and insulin-like growth factor
IGF) is depicted in Figure 1 and tabulated in Table E3
ormalized to expression in the rat esophagus, confirming
he overexpression of these transcripts in the cancer cells.
iscussion
n this study we have extensively characterized 3 cell lines
erived from a reflux-associated rat model of esophageal
ancer. We have shown that the cell lines are capable of
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G
TSropagation in vitro, as well as in vivo, in both subcutane-
us and orthotopic locations, confirming their malignant
otential. Furthermore, karyotype analysis confirmed highly
neuploid cell populations, with common underlying clonal
ranslocations (eg, translocation 7:11) that likely encode for
ncogenes critical in esophageal carcinogenesis. Of note, all
cell lines demonstrated loss of the Y chromosome, a
enetic aberration reported to be highly frequent in both
Figure 1. Results of quantitative RT-PCR reaction for ge
that seen in normal tissues. A, Vascular endothelial gr
much as the normal level and 230 and 23 times as muc
level of polo-like kinases (PLK) is 1770, 621, and 40 tim
AMY cell lines. C, Normalized values of cyclin depend
JB and AMY cell lines did not show overexpression o
esophageal mucosal cells. D, Expression of hypoxia-in
normal levels. E, Overexpression of insulin-like growth
seen in the AMY line, which did not have increased earrett esophagus and in esophageal adenocarcinomas.21-23 n
The Journal of Thoracicinally, the first global expression profiling of rodent esoph-
geal cancer lines identified numerous genes that have been
hown to be important in human esophageal carcinogene-
is,24,25 corroborating the validity of this model.
In our study the 3 cell lines we have generated engrafted, as
ell differentiated, keratinizing squamous cell carcinomas,
hich was somewhat unexpected because the primary tumors
rom which these were derived had unequivocal adenocarci-
f interest: the relative expression level compared with
factor (VEGF) level in the JA cell line is 541 times as
the normal level in the JB and AMY cell lines. B, The
at of the normal level compared with the JA, JB, and
inase 4 (CDK4) in the JA, JB, and AMY cell lines. The
s particular gene compared with that seen in normal
le factor 1 (HIF1) in the 3 cell lines compared with
r (IGF) in the JA and JB cell lines compared with that
ssion of IGF.nes o
owth
h as
es th
ent k
f thi
ducib
facto
xpreomatous components. We postulate that this discrepancy is
and Cardiovascular Surgery ● Volume 133, Number 3 767
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G
TSither an artifact of sampling caused by intratumoral hetero-
eneity or a result of discrepant genetic differences in the
denocarcinoma and squamous components, with the latter
aving a growth or survival advantage in vitro. Nevertheless,
he inherent squamous nature of the cell lines is a limitation,
lbeit their genesis in a Barrett-like background. Another lim-
tation of this model includes the relatively high preponderance
f tumors with an adenosquamous histology that is unusual in
uman Barrett esophagus–associated neoplasia. We believe
hat reflux-initiated chronic irritation might in part be respon-
ible for the emergence of squamous components in the rodent
umors because constant irritation is a known risk factor for
evelopment of squamous cell cancer. In addition, the native
odent esophagus contains keratinized squamous epithelium,
hich becomes further pronounced in reflux, and this might be
nother contributing factor to the higher proportion of adeno-
quamous lesions. At the same time, this model has numerous
dvantages as a proved in vivo model of metaplasia-neoplasia
n the rodent esophagus, wherein 100% of animals experience
arrett-like changes at 9 months, and 75% have neoplasia.
his provides a unique opportunity to study the effects of
ooperating carcinogens in the onset of malignancy, and con-
ersely, this model can serve as a platform for attempts at
hemoprevention and therapy.
Despite the squamous nature of the esophageal cancer lines,
hese can nevertheless serve as useful in vitro models for
dentifying new pathways involved in esophageal carcinogen-
sis and for testing novel therapies. For example, we recently
emonstrated 2 “drugable” pathways, the Hedgehog-signaling
athway and the epidermal growth factor receptor pathway, in
he JA, JB, and AMY cell lines.26 We further investigated the
fficacy of cyclopamine, a small-molecule inhibitor of the
edgehog pathway,27 and Iressa, an inhibitor of epidermal
rowth factor receptor tyrosine kinase, in the 3 lines and
onfirmed the efficacy of these agents in esophageal cancer.
hese cell lines are available from the investigators for drug
iscovery studies for esophageal cancer, such as high-
hroughput combinatorial testing, and will serve as a valu-
ble resource. Similarly, by publicly depositing the gene
xpression data in the National Center for Biotechnology
nformation’s Gene Expression Omnibus (http://www.ncbi.
lm.nih.gov/geo/), accessible through the GEO series ac-
ession number GSE1707, we hope to encourage research-
rs to explore additional pathways important in the
athogenesis of esophageal neoplasia, including molecular
argets for therapy and prevention of this disease.
In summary, we describe a rodent model of reflux-
nduced metaplasia and neoplasia in the esophagus, which
as generated 3 new cancer cell lines capable of continuous
n vitro and in vivo propagation. We present extensive
olecular characterization of these lines in anticipation ofheir use in the preclinical study of esophageal neoplasia.
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G
TSFigure E1. Reflux-induced tumor histology. A, Multilayered epithelium: a representative high-magnification pho-
tomicrograph of the esophageal mucosa subjected to surgically induced biliary reflux showing multilayered
epithelium in the rat esophagus. B, Barrett esophagus: a high-magnification photomicrograph of the columnar
metaplasia. C, Adenocarcinoma: remnants of squamous epithelium adjoining the adenocarcinomatous lesion in the
rat esophagus. The double arrow shows squamous esophageal mucosa, and the single arrow shows adenocar-
cinoma. D, Adenosquamous cancer: a typical adenosquamous lesion is shown that is common in a surgically
induced biliary rat reflux model. E, Invasive adenocarcinoma: submucosal extension of adenocarcinoma (double
arrow) is depicted adjoining the normal squamous epithelium (single arrow) . F, Adenocarcinoma (high magnifi-
cation): a high-magnification photomicrograph showing mucin-producing cells (arrows) in the adenocarcinoma of
the esophagus of reflux-induced tumor.69.e1 The Journal of Thoracic and Cardiovascular Surgery ● March 2007
Bonde et al General Thoracic SurgeryFigure E2. Cell line histology. A high-magnification cell cytospin preparation of the AMY cell line showing few
interspersed mucin-producing cells.G
TSFigure E3. Xenograft histology. A, A well-differentiated squamous cell cancer from the subcutaneous implant
specimen. B, A similar high-magnification photomicrograph showing epithelial pearls and squamous cell cancer
features of one of the orthotopic transplanted tumors.The Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 3 769.e2
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7
G
TSFigure E4. A, The JA cell line had 2 major clones, one with a modal number of 80 and the other with a modal
number of 78. A.1, Metaphase from first clone showing a deletion of chromosome 4 at band q22 (large arrow) and
the unbalanced 8:17 translocation (small arrow). A.2, Metaphase from second clone showing an unbalanced 7:11
translocation (long arrow) and the unbalanced 8:17 translocation (short arrow). A.3, Typical karyotype, with
chromosomes 17 and 18 being overrepresented. B, The JB cell line had 2 major clones with a modal chromosomal
number of 78. B.1, Metaphase from first clone showing the unbalanced 8:17 translocation. B.2, Metaphase from the
second clone showing the unbalanced 7:11 translocation (long arrow) and the unbalanced 8:17 translocation (short
arrow). Two small marker chromosomes (mar) were often, but not always, seen in both clones. B.3, Representative
karyotype from the JB cell line. C, The AMY cell line had the 7:11 translocation seen in JA and JB cell lines (C.1,
arrow) and was a single clone with a modal chromosomal number of 80 (C.2).69.e3 The Journal of Thoracic and Cardiovascular Surgery ● March 2007
Bonde et al General Thoracic SurgeryFigure E5. A, Ideogram of chromosome 4 showing deletion at band q22. B, Ideogram showing the unbalanced 7:11
translocation. C, Ideogram showing the unbalanced 8:17 translocation.The Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 3 769.e4
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G
TSABLE E1. Representative differentially expressed genes common to all 3 cell lines compared with normal esophageal
pithelium
ene ID Name GenBank accession no.
GICI01 2,3-Bisphosphoglycerate mutase BC062240
GIFD90 Actin-related protein 2/3 complex, subunit 1B NM_019289
GIEF73 Activated leukocyte cell adhesion molecule AB008538
GIBC32 Acyl-coenzyme A: cholesterol acyltransferase D86373
GIZB40 ADP-ribosylation-like 3 BQ204995
GIAA10 Aldehyde reductase 1 (low Km aldose reductase) (5.8 kb Pst I
fragment, probably the functional gene)
BC062034
GIAM85 ATPase, NaK transporting,  1 BC061968
I-R-C2-ms-b-07-0-UI Bone morphogenetic protein 6 AY184240
GICC80 Cadherin 3, type 1, P-cadherin (placental) XM_226426
GICV80 Carboxyl ester lipase X16054
GICV07 Caspase 3 BF408215
GIAC47 Cyclin-dependent kinase 4 BC063158
GIAS04 Cystatin C BM391630
GIAQ85 Cytochrome b5, outer mitochondrial membrane isoform BE111603
GICA13 Dihydro-orotate dehydrogenase XM_341685
GIAA27 Enolase 1,  BC063174
GIAM32 Follistatin BF389575
GIAD15 Glutathione reductase U73174
GIDR30 Glutathione synthetase L38615
GIAE95 Glyceraldehyde-3-phosphate dehydrogenase AF106860
GIAJ39 Growth factor–binding protein 1 AF142758
GIAN82 H2A histone family, member Z BQ201156
GICS51 High-mobility group box 2 BG380210
GIBD80 Hypoxia-inducible factor 1,  subunit AF057308
GICD34 Insulin-like growth factor 2 receptor U59809
GIAA38 Lactate dehydrogenase A X01964
GIEB96 Low-affinity Na-dependent glucose transporter (SGLT2) U29881
GIAC38 Moesin AF004811
GIAV15 Natriuretic peptide precursor type B BF395072
GIDE33 Nuclear RNA helicase, DECD variant of DEAD box family AF063447
GIDS30 Nuclear ubiquitous casein kinase 2 CA510075
GIBY81 Nucleosome assembly protein 1–like 1 BC061811
GIAC87 Ornithine decarboxylase 1 M16982
GIAG89 Ornithine decarboxylase antizyme 1 BG375293
GIAK21 P21 (CDKN1A)-activated kinase 1 U49953
GIAC88 Polo-like kinase homolog (Drosophila) U10188
GIBW70 Polypyrimidine tract binding protein BC061858
GIFD46 Preproenkephalin, related sequence BE111086
GIAS16 Profilin BI282907
GIAV34 Programmed cell death 8 (apoptosis-inducing factor) AB041723
GIAG94 RAN, member RAS oncogene family BM384578
GIFD16 S-adenosylhomocysteine hydrolase BC061841
GIBZ01 Sepiapterin reductase XM_342714
GIAE15 Serine/threonine kinase 16 D86220
GIAW68 Similar to high-mobility group protein 1 (HMG-1) (Amphoterin)
(heparin-binding protein p30) (LOC297927), mRNA
BQ198991
GIBK38 Similar to Kruppel-like factor 7 (ubiquitous) (LOC363243), mRNA BE112585
GIBK44 Solute carrier family 1, member 3 NM_019225
GIAH55 Solute carrier family 12, member 2 AF051561
GIDZ81 Solute carrier family 2, member 5 D13871
GIBC25 Thymic stromal-derived lymphopoietin, receptor NM_134465
GIAB90 Thymosin,  10 BE117292
GIDV78 Thyroid hormone-response protein 1 BE118252
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ene ID Name GenBank accession no.
GIEA66 Transketolase BM384351
GICK91 Vascular endothelial growth factor BE098396
GIBY29 Wingless-type MMTV integration site family, member 4 AF188608
GIAH24 Zinc finger protein 36 NM_133290DP, Adenosine diphosphate; ATPase, adenosine triphosphatase.
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G
TSABLE E2. Functional categories significantly overrepresented in the differentially regulated gene sets
. Functional categories significantly downregulated in all 3 cancer cell lines
O functional
ategory GO ID Gene category P value Gene name
GenBank
accession no.
UniGene
ID
olecular function GO:0004289 Subtilase activity 3.52E-12 Subtilisin-like endoprotease L31894 Rn. 950
Proprotein convertase
subtilisin/kexin type 7
U36580 Rn. 10653
iological process GO:0006508 Proteolysis and
peptidolysis
.001873 Subtilisin-like endoprotease L31894 Rn. 950
Proprotein convertase
subtilisin/kexin type 7
U36580 Rn. 10653
Insulin-degrading enzyme X67269 Rn. 45029
Cathepsin K NM_031560 Rn. 5598
Cathepsin E BC062002 Rn. 92738
Cathepsin L BC063175 Rn. 1294
N-arginine dibasic convertase 1 NM_012993 Rn. 2081
Matrix metalloproteinase 2 (72-
kd type IV collagenase)
X71466 Rn. 6422
olecular function GO:0004222 Metalloendopeptidase
activity
.002101 Insulin-degrading enzyme X67269 Rn. 45029
N-arginine dibasic convertase 1 NM_012993 Rn. 2081
Matrix metalloproteinase 2 (72-
kd type IV collagenase)
X71466 Rn. 6422
olecular function GO:0004364 Glutathione transferase
activity
.002243 Glutathione-S-transferase, 
type 3 (Yb3)
BC059130 Rn. 6036
Glutathione-S-transferase,  2 BI302435 Rn. 625
olecular function GO:0005201 Extracellular matrix
structural constituent
.0023 Elastin M60647 Rn. 54384
Procollagen, type I,  2 AF121217 Rn. 107239
iological process GO:0006730 One-carbon compound
metabolism
.003204 Dihydrofolate reductase BF406309 Rn. 24681
Carbonic anhydrase 3 NM_019292 Rn. 1647
olecular function GO:0004252 Serine-type
endopeptidase activity
.004305 Subtilisin-like endoprotease L31894 Rn. 950
Proprotein convertase
subtilisin/kexin type 7
U36580 Rn. 10653
Reelin NM_080394 Rn. 98353
ellular component GO:0005615 Extracellular space .004489 Insulin-like growth factor-
binding protein 5
AF139830 Rn. 1593
Glypican 3 M22400 Rn. 9717
Cathepsin E BC062002 Rn. 92738
Insulin-like growth factor 2 X14834 Rn. 964
Clusterin M16975 Rn. 1780
Cathepsin L BC063175 Rn. 1294
Cathepsin K NM_031560 Rn. 5598
ATP-binding cassette, subfamily
D (ALD), member 3
D90038 Rn. 7024
Albumin V01222 Rn. 34353
Secreted acidic cysteine-rich
glycoprotein
BM384341 Rn. 98989
Kinase insert domain protein
receptor
U93306 Rn. 88869
Superoxide dismutase 3,
extracellular
Z24721 Rn. 10358
Secretoglobin, family 1A,
member 1 (uteroglobin)
AI009524 Rn. 2206
Aquaporin 1 X67948 Rn. 1618
Branched chain
aminotransferase 2,
mitochondrial
BC061790 Rn. 981
CD24 antigen BC064439 Rn. 6007
Matrix Gla protein BM384331 Rn. 2379
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. Functional categories significantly downregulated in all 3 cancer cell lines
O functional
ategory GO ID Gene category P value Gene name
GenBank
accession no.
UniGene
ID
olecular function GO:0004842 Ubiquitin-protein ligase
activity
.008121 Progestin-induced protein X64411 Rn. 54812
Ubiquitin-conjugating enzyme
E2D 2
BE115845 Rn. 7390
ellular component GO:0005578 Extracellular matrix .010148 Secreted acidic cysteine-rich
glycoprotein
BM384341 Rn. 98989
Elastin M60647 Rn. 54384
Extracellular matrix protein 1 XM_215645 Rn. 97792
Procollagen, type I,  2 AF121217 Rn. 107239
Glypican 3 M22400 Rn. 9717
Matrix metalloproteinase 2
(72-kd type IV collagenase)
X71466 Rn. 6422
olecular function GO:0008483 Transaminase activity .024083 Branched chain
aminotransferase 2,
mitochondrial
BC061790 Rn. 981
Aminolevulinic acid synthase 1 NM_024484 Rn. 97126
olecular function GO:0019838 Growth factor binding .024465 Insulin-like growth factor-
binding protein 5
AF139830 Rn. 1593
Insulin-like growth factor-
binding protein 6
BQ204169 Rn. 6431
olecular function GO:0008270 Zinc ion binding .029383 Solute carrier family 11,
member 2
AF008439 Rn. 11418
Carbonic anhydrase 3 NM_019292 Rn. 1647
Matrix metalloproteinase 2 (72-
kd type IV collagenase)
X71466 Rn. 6422
olecular function GO:0016787 Hydrolase activity .030582 Acid phosphatase, prostate M32397 Rn. 40121
Reelin NM_080394 Rn. 98353
N-arginine dibasic convertase 1 NM_012993 Rn. 2081
Matrix metalloproteinase 2 (72-
kd type IV collagenase)
X71466 Rn. 6422
Cathepsin K NM_031560 Rn. 5598
Insulin-degrading enzyme X67269 Rn. 45029
Cathepsin E BC062002 Rn. 92738
Cathepsin L BC063175 Rn. 1294
Nudix (nucleoside diphosphate-
linked moiety X)-type motif 6
U58289 Rn. 83600
Proprotein convertase
subtilisin/kexin type 7
U36580 Rn. 10653
Dynamin 1 X54531 Rn. 10354
Adenosine monophosphate
deaminase 3
U90888 Rn. 11106
Subtilisin-like endoprotease L31894 Rn. 950
olecular function GO:0008237 Metallopeptidase
activity
.031231 Insulin-degrading enzyme X67269 Rn. 45029
N-arginine dibasic convertase 1 NM_012993 Rn. 2081
Matrix metalloproteinase 2 (72-
kd type IV collagenase)
X71466 Rn. 6422
olecular function GO:0005520 Insulin-like growth
factor binding
.038283 Insulin-like growth factor-
binding protein 5
AF139830 Rn. 1593
Insulin-like growth factor-
binding protein 6
BQ204169 Rn. 6431
ellular component GO:0005576 Extracellular .040352 Acid phosphatase, prostate M32397 Rn. 40121
Insulin-like growth factor 2 X14834 Rn. 964
Insulin-like growth factor- AF139830 Rn. 1593binding protein 5
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G
TSable E2. Continued
. Functional categories significantly downregulated in all 3 cancer cell lines
O functional
ategory GO ID Gene category P value Gene name
GenBank
accession no.
UniGene
ID
Extracellular matrix protein 1 XM_215645 Rn. 97792
Matrix Gla protein BM384331 Rn. 2379
Insulin-like growth factor-
binding protein 6
BQ204169 Rn. 6431
olecular function GO:0004197 Cysteine-type
endopeptidase activity
.050041 Cathepsin K NM_031560 Rn. 5598
Cathepsin L BC063175 Rn. 1294
. Functional categories significantly upregulated in all 3 cancer cell lines
O functional
ategory GO ID Gene category P value Gene name
GenBank
accession no.
UniGene
ID
ellular component GO:0005694 Chromosome 2.67E-12 High-mobility group box 2 BG380210 Rn. 2874
H2A histone family, member Z BQ201156 Rn. 112573
iological process GO:0007286 Spermatid development 1.92E-04 Thymosin,  10 BE117292 Rn. 5983
RAN, member RAS oncogene
family
BM384578 Rn. 107698
olecular function GO:0006330 Single-stranded DNA
binding
.001618 Nuclear ubiquitous casein
kinase and cyclin-dependent
kinase substrate
NM_022799 Rn. 21324
Polypyrimidine tract-binding
protein 1
BC061858 Rn. 64440
iological process GO:0030036 Actin cytoskeleton
organization and
biogenesis
.003425 Thymosin,  10 BE117292 Rn. 5983
Profilin 1 BI282907 Rn. 1152
iological process GO:0000074 Regulation of cell cycle .004719 Cyclin-dependent kinase 4 BC063158 Rn. 6115
RAN, member RAS oncogene
family
BM384578 Rn. 107698
Nuclear ubiquitous casein
kinase and cyclin-dependent
kinase substrate
NM_022799 Rn. 21324
Cell-cycle protein p55CDC NM_171993 Rn. 9262
olecular function GO:0003690 Double-stranded DNA
binding
.005205 Nuclear ubiquitous casein
kinase and cyclin-dependent
kinase substrate
NM_022799 Rn. 21324
High-mobility group box 2 BG380210 Rn. 2874
olecular function GO:0008415 Acyltransferase activity .010213 Spermidine/spermine N1-acetyl
transferase
BC060588 Rn. 107986
Acyl-coenzyme A: cholesterol
acyltransferase
D86373 Rn. 59
iological process GO:0006096 Glycolysis .010961 Glyceraldehyde-3-phosphate
dehydrogenase
AF106860 Rn. 91450
Lactate dehydrogenase A X01964 Rn. 107896
olecular function GO:0003676 Nucleic acid binding .013416 Polypyrimidine tract-binding
protein 1
BC061858 Rn. 64440
Zinc finger protein 36 NM_133290 Rn. 82737
iological process GO:0007264 Small GTPase-mediated
signal transduction
.017968 RAN, member RAS oncogene
family
BM384578 Rn. 107698
P21 (CDKN1A)-activated kinase
1
U49953 Rn. 9149
ADP-ribosylation factor-like 3 BQ204995 Rn. 9538
olecular function GO:0005125 Cytokine activity .020391 Thymic stromal-derived
lymphopoietin, receptor
NM_134465 Rn. 22704Bone morphogenetic protein 6 AY184240 Rn. 40476
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. Functional categories significantly upregulated in all 3 cancer cell lines
O functional
ategory GO ID Gene category P value Gene name
GenBank
accession no.
UniGene
ID
ellular component GO:0005634 Nucleus .027878 Programmed cell death 8
(apoptosis-inducing factor)
AB041723 Rn. 8124
H2A histone family, member Z BQ201156 Rn. 112573
Polypyrimidine tract-binding
protein 1
BC061858 Rn. 64440
Nuclear ubiquitous casein
kinase and cyclin-dependent
kinase substrate
NM_022799 Rn. 21324
Polo-like kinase 1 (Drosophila) U10188 Rn. 11034
Zinc finger protein 36 NM_133290 Rn. 82737
RAN, member RAS oncogene
family
BM384578 Rn. 107698
Hypoxia-inducible factor 1, 
subunit
AF057308 Rn. 10852
High-mobility group box 2 BG380210 Rn. 2874
iological process GO:0007049 Cell cycle .032999 Cyclin-dependent kinase 4 BC063158 Rn. 6115
Polo-like kinase 1 (Drosophila) U10188 Rn. 11034
olecular function GO:0005516 Calmodulin binding .034449 Brain-abundant, membrane-
attached signal protein 1
BE110763 Rn. 37779
Calponin 3, acidic BC062020 Rn. 57635
olecular function GO:0004691 cAMP-dependent
protein kinase activity
.035111 Cyclin-dependent kinase 4 BC063158 Rn. 6115
Serine/threonine kinase 16 D86220 Rn. 13308
olecular function GO:0004682 Protein kinase CK2
activity
.039394 Cyclin-dependent kinase 4 BC063158 Rn. 6115
Serine/threonine kinase 16 D86220 Rn. 13308
ellular component GO:0005856 Cytoskeleton .04869 Thymosin,  10 BE117292 Rn. 5983
Profilin 1 BI282907 Rn. 1152
Moesin AF004811 Rn. 2762
olecular function GO:0004674 Protein serine/threonine
kinase activity
.049573 Cyclin-dependent kinase 4 BC063158 Rn. 6115
P21 (CDKN1A)-activated kinase
1
U49953 Rn. 9149
Polo-like kinase 1 (Drosophila) U10188 Rn. 11034
Serine/threonine kinase 16 D86220 Rn. 13308
nto-Express (OE) analysis of the differentially regulated gene lists uses Gene Ontology (GO) terms to identify functional categories significantly
verrepresented within the downregulated (A) or upregulated (B) gene sets. OE also computes accompanying significance values (P values) by comparing
he observed number of genes in a given category with the total number of genes within that category on the array. We focused our attention on those
unctional categories containing at least 2 genes at a P value of less than .05. Genes can be associated with more than 1 GO term. ATP, Adenosine
riphosphate; GTPase, glutathione triphosphatase; ADP, adenosine diphosphate; cAMP, cyclic adenosine monophosphate.
G
TSABLE E3. Results of quantitative real-time polymerase chain reaction analysis for 5 genes of interest in cell lines JA, JB,
nd AMY
VEGF CDK4 PLK IGF HIF
ormal 1 1 1 1 1
A 541.1932 102.5369 1770.572 380.038 352.1387
B 230.7201 0.570382 621.6678 7.260153 75.06144
MY 23.91759 0.239816 40.22443 0.659754 4.257481
hanges in expression level relative to the normal esophageal mucosal control cell line are indicated by the values in the table. VEGF, Vascular endothelial
rowth factor; CDK4, cyclin dependent kinase 4; PLK, polo-like kinases; IGF, insulin-like growth factor; HIF, hypoxia-inducible factor.
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